<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Durvalumab</id>
	<title>Durvalumab - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Durvalumab"/>
	<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Durvalumab&amp;action=history"/>
	<updated>2026-04-28T23:26:38Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://idwiki.org/index.php?title=Durvalumab&amp;diff=10381&amp;oldid=prev</id>
		<title>Aidan: Created page with &quot;* Human IgG1k monoclonal antibody that blocks PD-L1 from interacting PD-1 and CD-80 * Indicated for urothelial carcinoma, small cell lung cancer, non-small cell lung cancer * Adverse effects include ** Cardiac: hypertension (6%), myocarditis (rare) ** Dermatologic: rash with pruritus (22%) ** Gastrointestinal: abdominal pain (10%), anorexia (14%), constipation (12%), diarrhea (18%), colitis (2%), nausea/vomiting (14%) ** General: edema (8%), fatigue (...&quot;</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Durvalumab&amp;diff=10381&amp;oldid=prev"/>
		<updated>2024-02-07T19:43:46Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;* Human IgG1k monoclonal antibody that blocks PD-L1 from interacting PD-1 and CD-80 * Indicated for &lt;a href=&quot;/index.php?title=Urothelial_carcinoma&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Urothelial carcinoma (page does not exist)&quot;&gt;urothelial carcinoma&lt;/a&gt;, &lt;a href=&quot;/Small_cell_lung_cancer&quot; title=&quot;Small cell lung cancer&quot;&gt;small cell lung cancer&lt;/a&gt;, &lt;a href=&quot;/index.php?title=Non-small_cell_lung_cancer&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Non-small cell lung cancer (page does not exist)&quot;&gt;non-small cell lung cancer&lt;/a&gt; * Adverse effects include ** Cardiac: &lt;a href=&quot;/Hypertension&quot; title=&quot;Hypertension&quot;&gt;hypertension&lt;/a&gt; (6%), &lt;a href=&quot;/Myocarditis&quot; title=&quot;Myocarditis&quot;&gt;myocarditis&lt;/a&gt; (rare) ** Dermatologic: rash with pruritus (22%) ** Gastrointestinal: abdominal pain (10%), anorexia (14%), constipation (12%), diarrhea (18%), colitis (2%), nausea/vomiting (14%) ** General: edema (8%), fatigue (...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;* Human IgG1k monoclonal antibody that blocks PD-L1 from interacting PD-1 and CD-80&lt;br /&gt;
* Indicated for [[urothelial carcinoma]], [[small cell lung cancer]], [[non-small cell lung cancer]]&lt;br /&gt;
* Adverse effects include&lt;br /&gt;
** Cardiac: [[hypertension]] (6%), [[myocarditis]] (rare)&lt;br /&gt;
** Dermatologic: rash with pruritus (22%)&lt;br /&gt;
** Gastrointestinal: abdominal pain (10%), anorexia (14%), constipation (12%), diarrhea (18%), colitis (2%), nausea/vomiting (14%)&lt;br /&gt;
** General: edema (8%), fatigue (24%)&lt;br /&gt;
** Hematologic: [[immune-mediated thrombocytopenic purpura]] (rare)&lt;br /&gt;
** Hepatobiliary: elevated liver tests (6%), hepatitis (2%), pancreatitis (rare)&lt;br /&gt;
** Hypersensitivity: infusion reactions (2%)&lt;br /&gt;
** Infection (26%): [[UTI]] and [[pneumonia]] most commonly&lt;br /&gt;
** Metabolic: adrenal insufficiency (rare), diabetes mellitus (rare), hyperthyroidism (8%), hypophysitis (rare), hypothyroidism (12%), thyroiditis (2%)&lt;br /&gt;
** MSK: pain (12%)&lt;br /&gt;
** CNS: aseptic meningitis or encephalitis (rare), headache (11%), insomnia (10%)&lt;br /&gt;
** Ophthalmic: [[uveitis]] (rare)&lt;br /&gt;
** Renal: increased creatinine (5%)&lt;br /&gt;
** Respiratory: cough or dyspnea (40%), severe cough or dyspnea (1%), dysphonia (4%), pneumonitis (3%, but up to 34% in NSCLC)&lt;br /&gt;
&lt;br /&gt;
[[Category:Monoclonal antibodies]]&lt;br /&gt;
[[Category:Oncology]]&lt;/div&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
</feed>